chrisvoncsefalvay/vaers-outcomes huggingface dataset:
1st Dose vaccine given on 01-28-2021. Symptoms of only headache that night. 2nd Dose given 35 days later on 3-4-2021 instead of the 28th day due to vaccine shortage. Headaches that evening and continued to next day 3-5-2021. Took Motrin. Chills developed at around 330pm next day followed by low grade fever 99 F. Headaches worsened by 5pm. Took 400mg Motrin. Tachycardia around 530pm. BP taken read 153/97. P:116. Took 10mg Propranolol I had on hand. BP dropped in 2 hrs. All symptoms subsided by 9pm that night. Did not seek medical help as I was able to manage with propranolol. Just wanting to report increased BP/tachycardia as possible side effects and symptoms occured the next day.
02/22/2021 experienced severe shortness of breath that left him incapacitated; continued with progressively worsening symptoms; saw primary doctor who began a series of tests. 3/2/21 CXR; 3/4/21 Covid test (results neg); 3/11/21 Respiratory Clinic for PFT's; 3/15/21 labs Chem panel, CBC, Thyroid, cardiac enzymes; 3/19/21 in ER for CXR, CT scan of chest, labs, IV meds, O2; discharged home with new meds and home oxygen; 3/24/21 back to the ER with worsening shortness of breath with CXR labs, oxygen, ADMITTED to Hospital 3/25/21 ECHO, began Heparin drip for small blood clot in right ventricle; transferred to Hospital on 3/27/21 for bilateral thoracentesis on 3/28/21; has telemetry with pulse ox, daily labs, heparin drip, and new cardiac medications; unable to sleep lying down; 4/5/21 CT guided needle biopsy for right lung mass; no cancer, but a pseudo tumor of white blood cells; discharged on 4/8/21 and had a run of V-tach while getting in the car; defibrillated twice by AICD; readmitted on 4/8/21; discharged again on 4/9/21 on HOSPICE. From 4/9/21 until 4/28/21 had 6 additional shocks by AICD related to sustained SVT and VTach; generator (battery) in AICD now almost depleted and requiring changing; 6/30/21 off Hospice for generator replacement procedure; 7/1/21 AICD generator replaced at hospital; 7/15/21 saw Dr; 8/12/21 repeat ECHO; 8/19/21 Saw the cardiologist; continues with recovery
pt recv vax 22JUL92 & stated had a  rxn & discontinued the vax series; No further details were provided;
Two days after vaccination patient developed a rash over their entire body. Patient went to the doctor and was prescribed Fexofenadine 180mg once daily. Patient reports no fever and just a rash. Patient also reports that that miss a dose of Fexofenadine the rash returns after just 1 missed dose. Patient reported this to the pharmacy at the appointment for their second dose. We administered dose and observed the patient for 30 minutes and no immediate reaction occurred. Patient has 1 more refill of Fexofenadine at the time of the second vaccine that they will pick up and will last them one more month. Patient was advised that if any other reactions occur, they should contact their doctor.
Rash - Information has been received from a health care professional concerning a 13 month old female who on 18 mar 2000 was vaccinated with one dose of varicella virus vaccine live (site unknown).  On 07 apr 2000 the patient developed a rash.  The patient sought unspecified medical treatment Additional information has been requested
Patient received vaccine early. The first dose of the was received 5/7/2021 and was not due for the second dose of vaccine until 5/28/2021. Received second dose of vaccine 5/19/2021
I did not have an adverse reaction to the vaccine. I was in an airplane with very rough turbulence. I felt something strange in my brain. I also have two shunts from a previous surgery in my brain. I have terrible headaches and dizziness. I have to the emergency room to be monitored and they tried a procedure, but it didn't work. I am currently taking steroids. I have not been able to leave my house for a week.
she developed " a myopathy,  weakness, (almost like a paralysis), mostly in both lower extremities."; she developed " a myopathy,  weakness, (almost like a paralysis), mostly in both lower extremities."; she developed " a myopathy,  weakness, (almost like a paralysis), mostly in both lower extremities."; This is a spontaneous report from a contactable pharmacist. A 30-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration on 15Apr2021 (Lot number and expiration date was not reported) as single dose for COVID-19 immunisation. Medical history included history of a bone marrow transplant from 2018 (reported as 3 years ago) to an unknown date. The patient's concomitant medications were not reported. She was currently not taking any immunosuppressant medications at this time. On 19Apr2021, 4 days after receiving the 1st dose, she developed a myopathy, weakness, (almost like a paralysis), mostly in both lower extremities. The Medical Director and the Neurologist are looking for any data Pfizer has on this type of adverse event, any treatment recommendations based from the post EUA AE reports received by Pfizer DSU. The outcome of the events was unknown.  Information about the Lot/batch number has been requested.; Sender's Comments: Based on temporal association a contributory role of BNT162B2  cannot be totally excluded.  Case will be reassessed if additional information is received.   The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Ethics Committees and Investigators, as appropriate.
Serum sickness, headache, weakness. Onset of symptoms, 4 to 6 hours following IMZ administration. Symptoms lasted 24 hours.
Had the same rash that he got; This spontaneous case was reported by a consumer and describes the occurrence of RASH (Had the same rash that he got) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced RASH (Had the same rash that he got). At the time of the report, RASH (Had the same rash that he got) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported. No treatment details were reported.   Most recent FOLLOW-UP information incorporated above includes: On 16-Jul-2021: TCR  document received on 16-JUL-2021 Contain AE outcome.
Tightening of chest Difficulty breathing Nausea Pain at injection site for over 7 days Fever Tired needing to rest
4/5/21 Patient presented to ED w/fever, weakness, cough and SOB. Initial temp was 103 and RA pulse ox 87%. Signs of AKI with cr up from baseline of 0.9 to 1.49 and he was hyponatremic (Na 130). Pt was admitted on O2 per NC, IVF, Decadron and Remdesivir. He completed a 5 day course of Remdesivir. AKI and hyponatremia resolved. he was not able to be weaned off oxygen. H was discharged on 4/13 on oxygen 2L per NC and Decadron to complete a 10 day course.
Information has been received from a physician concerning a 6 year old male who on 30-MAY-2001 was vaccinated with a dose of Varivax (lot# 635789/1892K). On 12-JUL-2006 the patient developed herpes zoster in the cranial nerve C-8. Unspecified medical attention was sought. Subsequently, the patient recovered. There was no product quality complaint involved. Additional information has been requested.
3/24/03 Reported to Infection control nurses at Hospital that one week after vaccine developed deep muscle pain in thighs, calves and arms.  Commented that it was larger muscles.  Takes motrin or ibuprofen with relief during day but did not want to take at night.  Says keeps her awake at night. Infection control called Dr. who ordered Sed. rate, C reactive protein, U/A,and CPK.  Told by infection control nurse that tests were benign.  Infection control spoke with patient on 4/2/03, who stated that pain isn't causing her to be unable to function but is still disturbing sleep.  Was told by infection control nurse to let her know if this was still a problem in one week.  Says did not have this before getting vaccine.
Blinded, call pouring sweat as if a cup of water was poured over her head, shaking, passed out, loss of all feelings including ice cold water bottle placed on her neck she could not feel, unable to speak. This only lasted about 5 minutes and then she was fine. She just had to go to the restroom. Nothing else since. My other daughter (13) and I (41) had no reactions. Name on bottle was: Pfizer FA7485
vomitting began around 11:00pm on 10/21, 16 episodes of vomitting through Friday 10/22 morning. Vomitting on 10/23 every hour and woke up with intense eye pain. Admitted to hospital with streptococcus group A bacteremia and eye infection with loss of vision.
"This is a 74y.o. male with PMH of CAD s/p 4 stents, Ischemic cardiomyopathy, HTN, COPD, and Tobacco dependence who presented to the ED with complaint of abd pain, diarrhea. Symptoms first started on 4/10." "During this hospital stay, his oxygen demand was increased up to 5L oxygen. Completed steroids on 4/24. Patient didn't pass home O2 evl, still requiring 2-3 L oxygen ambulating. Case manager to arrange oxygen tank for patient to go home with."    Discharged home on 04/26/21.
Small raised red bumps appeared on hands/fingers approx 10 days post vaccination. Bumps were itchy and grew in size within 24 hours. Affected areas were not pus-filled and have responded moderately to antihistamine topical cream and cetirizine orally.  Quantity of affected bumps has decreased since initial outbreak, however new spots are still appearing. Patient is currently on day 10 of outbreak.
This spontaneous report as received from a nurse refers to a 87 years old female patient with atrial fibrillation, joint pain, osteoarthritis and MACROBID allergy. The patient was vaccinated with live ZOSTAVAX on 03-JUN-2008 at a since closed pharmacy. No other co-suspects were reported. Concomitant medications included digoxin, metoprolol, warfarin, CELEBREX, fish oil and vitamin D (unspecified). On an unknown date the patient experienced severs case of shingles on the buttocks and in the groin and presented at the physician's office on 16-JAN-2013. VALTREX was given as treatment. The outcome of the event was reported as not recovered. Additional information has been requested.
Swollen (R) arm. Swollen at site of KINRIX. Went to PMD.
Chills; fever; underneath arm swollen; underneath my arm is swollen going into the third day after my shot which is painful; This is a spontaneous report from a contactable consumer, the patient. A 50-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Ew0153) via an unspecified route of administration in the left arm on 14Apr2021 at 15:00 (at the age of 50-year-old) as 0.3ml single dose for COVID-19 immunisation. Medical history was reported as no. The patient had no known allergies to food, medications or other products. The patient received medications (unspecified) within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 15Apr2021 at 15:30 the patient experienced chills, fever for two days, underneath arm swollen which was going into the third day after shot and was painful. The events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of fever was recovered on 17Apr2021 after a duration of 2 days; while that of chills, underneath arm swollen which was going into the third day after shot and was painful was not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
Two weeks after the first Pfizer Covid-19 vaccine, the patient experienced vertigo-like symptoms with severe nausea, vomiting and diarrhea. He was admitted to the hospital where he stayed for a few days. After treating for vertigo, symptoms subsided. These symptoms have recurred several times since then. He was hospitalized again last week for several days. He also made another trip to the ER. Other times he was treated at home with prescribed medicine. He had symptoms of encephalitis. After multiple tests proved inconclusive, we now suspect this was an adverse event brought about by the first Covid-9 vaccine.
This case was reported by a consumer via call center representative and described the occurrence of influenza-like symptoms in a adult male patient who received SHINGRIX for prophylaxis. On an unknown date, the patient received the 1st dose of SHINGRIX (intramuscular) .5 ml. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced influenza-like symptoms and chills. On an unknown date, the outcome of the influenza-like symptoms and chills were recovered/resolved. It was unknown if the reporter considered the influenza-like symptoms and chills to be related to SHINGRIX. Additional details reported as follows: The caller was inquiring about taking prophylaxis TYLENOL prior to receiving the second series of the SHINGRIX vaccine which would be the day after reporting. He received the initial vaccine 4 months before the date of reporting and had flu like symptoms and chills which lasted for several days and then resolved. He was referred back to his physician regarding this question. The patient's physician's name and telephone number could not be obtained secondary to call flow.
Fever 101 degrees, chills, bones ached, body pain, fatigue 2 days, swollen itchy red and sore left arm still going on
Day after my vaccine I developed overall body aches and fatigue.  3 days after the vaccine I developed a headache, on 1/5/21 I tested positive for covid.  My daughter also tested positive on 1/5/21.
This spontaneous report has been received from a public health nurse and refers to an unknown number of patients of unknown ages and genders. The patients' medical histories, concurrent conditions, drug allergies/reactions, and concomitant therapies were not reported. On unknown dates, the patients were vaccinated with improperly stored doses of PEDVAXHIB (lot # M001814, expiration date 15-OCT-2018; doses, routes of administration, and frequencies were not reported) for prophylaxis. The vaccines were exposed to a temperature excursion range from 32°F to 35°F for a total time frame of 53 minutes. A previous temperature excursion measured a temperature of 34°F recorded on a data logger. No adverse effects were reported. Additional information has been requested.
Redness and heat at DTAP site from 2 days prior.  Diagnosis of cellulitis and treated with Keflex.
Patient reported blurry vision about 8 minutes after receiving COVID-19 booster today. Patient remained in observation and after 30 minutes, reports blurry vision had improved some. Denied any headache, dizziness, shortness of breath, eye pain. Recommended she contact either ophthalmology or primary care provider, seek urgent care/ED services if vision worsens/does not improve today.
Patient called and notified that the day after injection her arm was twice the size an extremely painful." BENEDRYL DM and started to feel better. Reaction Resolved.
Started with body aches at first, severe chills and fever (101.1) all throughout the night, headache, nausea. Currently (46 hours later) - body aches, temperature of 100.2.
Patient came in on 10/26/2023 to report this event. Said he felt fine the day of his vaccines (flu and covid), then the next evening, he felt a sudden pressure in his chest, a funny feeling in his throat, his pulse was very fast and erratic, and his BP was high. He waited about 10 min to see if it would subside, and it didn't so he went to the ER. There they gave him Nitroglycerin x1 time, and ASA and observed him overnight. They described his condition as a "heart event". His symptoms subsided after the meds were given and he went home the next day. It took him 1 week to feel completely better. All tests done at the hospital showed no damage done to his heart.
Started as a small red rash with a dark purple ring around the injection site the following morning.   At around 24 hours out, the rash began to spread around the thigh.  At 48+ hours out, almost the entire thigh is covered in a rash, hot to the touch, with a 99.9 fever.
Numbness in left side of face directly following the injection. However, Right side of face is what started to droop in eye and mouth. Area above right eye  wasn?t responding to smiling.  Slurring of speech and obvious signs of difference of facial features observed by multiple persons not knowing I?ve just received a vaccine.
Extreme body aches, chills, nausea and mild fever.  Local reaction of swelling, redness and itching at the injectin site.  Symptoms lasted for 4 days. Treated with acetaminophen, rest and fluids
This spontaneous report was received from a Registered nurse regarding a 15 year old patient of unknown gender. The patient's medical history, concurrent conditions and concomitant medications were not reported. On 28-JUL-2017, the patient was vaccinated with improperly stored dose of GARDASIL 9 lot# N004798 with expiration date: 31-OCT-2019 (dosing details and route of administration was not reported) for prophylaxis. No adverse effects were reported. The storage temperature was 47 degrees Fahrenheit to 77 degrees Fahrenheit (49F) and time frame was 14 hours. There was no previous temperature excursion. Digital data logger was involved. No product quality complaint was involved. This is one of the several reports received from the same reporter. Sender's Comments: US-009507513-1804USA005153.
No ADR A Pfizer bivalent dose was administered as a 1st primary series dose
SIDE EFFECTS; LINGERING PAIN WAS GONE; This spontaneous report received from a patient concerned a 61 year old male. The patient's height, and weight were not reported. The patient's past medical history included: physical therapy, and acupuncture, and concurrent conditions included: shoulder rotator cuff injury. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 043A21A, and expiry: UNKNOWN) dose was not reported, administered on 01-MAY-2021 for prophylactic vaccination. No concomitant medications were reported.  On 2021, the patient experienced side effects, and lingering pain was gone. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the side effects and lingering pain was gone was not reported. This report was non-serious. This case, involving the same patient is linked to 20220513079.; Sender's Comments: V0: Medical assessment comment is not required as per standard procedure as case is assessed as non-serious.
patient received first covid pfizer vaccine on 5/15. On/around 5/29 patient developed a red, bumpy, painful rash. Patient was evaluated on 6/1, culture of rash sent to lab.
Seen on 3/30/14 for cellulitis of the arm around smallpox vaccine as well as body aches and general feeling of malaise. Was administered Motrin and follow-up in next couple of days if symptoms worsen. Pt f/u the next day with a rash covering upper torso and few spots on thighs. Was given Benadryl to help with the itching. Pt returned to clinic the following day with symptoms not resolving. Discussed with pt the possibility of the rash being fungal or folliculitis and either course of treatment would require medication that is DNIFing. Pt decline medication at the time due to flying schedule. Pt instructed to return if symptoms worsened.
Seven days after administration I experienced swelling and a strange feeling that was almost like itching at the vaccination site. It was about 3 inches in diameter, swollen and red with some surface blotches. I took a Benedryl, and the next day the site was much better.
This spontaneous report as received from a pharmacist refers to a female patient of unknown age. On 10-SEP-2015, the patient was vaccinated with a dose of ZOSTAVAX, (dose, lot number and expiration date were not reported) intramuscularly rather than subcutaneously. There was no concomitant medication provided. In approximately September 2015, the patient called the pharmacy after receipt of the ZOSTAVAX and complained of a little rash and swelling around the injection site. The patient was recommended to put ice over the site. The outcome of rash and injection site swelling was reported as recovered (unspecified date in September 2015). Relatedness between the therapy was ZOSTAVAX and the events was not reported. Additional information has been requested.
Headache; chills; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache), CHILLS (chills) and FATIGUE (fatigue) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HEADACHE (Headache), CHILLS (chills) and FATIGUE (fatigue). At the time of the report, HEADACHE (Headache), CHILLS (chills) and FATIGUE (fatigue) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications reported by investigator o No treatment medications provided by the reporter.
10 min after 2nd moderna vaccine injection, tingling arms/feet mouth, followed by swelling throat, tongue, hoarsness improved with epi pen and 50 Benadryl 10 min given in field 1o min after symptoms began
Pt recieved vaccine @ 1112 and immediately fainted, eyes rolled back in his head. Noted to be very pale, diaphoretic and cool to touch. B/P 72/42, HR-44, 02 sat 96%ra. Pt reports anxiety and history of passing out at dentist office. 1120 b/p 58/40, 98%ra, hr-68. cont to be diaphoretic, cool to touch and pale. 1137 pt reports feeling better was given crackers and water @ 1115. EMS called by site lead. EMS assessed pt and he refused to go to the hospital. Pt encouraged to follow up with MD. 1157 02 sat 96% hr-62, pt ambulated with staff for 20 minutes prior to dischargeat 1158. Team Lead okayed pt to drive himself home.
This spontaneous report as received from a registered nurse refers to a patient of unknown age and gender. Medical history and concurrent conditions were not reported. On 13-SEP-2015, the patient was inadvertently vaccinated with a dose of GARDASIL (lot number and dosing details were not reported) which expired on 26-JUN-2015. Concomitant medications were not reported. No adverse effects reported. Additional information has been requested.
Bilateral red eyes, hoarseness, cough, headache, chest tightness, muscle ache, sore throat, pain in right side radiating up to chest - neck to ear on right side.
Patient received last of 3 Gardasil vaccinations. Approximately 2 months later was diagnosed with Hodgkins Lymphoma.  Symptoms became evident just after the third vaccination. 3/9/09-records received-office visit 1/22/09-C/O tired SOB, Irregular menses which is secondary to chemo. Monitor labs if not better 3-6 mos.  4/29/09-records received-office visit 1/23/08 for C/O possible brachial cleft cyst or neck mass.  Past 2 weeks swelling in left axilla. Decreased energy and generalized pruritus.
Moderna Covid 19 Vaccine EUA. 10 days after shot got flu like symptoms, vomiting, headache, and joint and muscle aches for about 5 hours.  Started feeling better after midnight but still sore stomach and headache.